MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells.
about
Multistep model of cervical cancer: participation of miRNAs and coding genesMicroRNA in cervical cancer: OncomiRs and tumor suppressor miRs in diagnosis and treatmentUnraveling 50-Year-Old Clues Linking Neurodegeneration and Cancer to Cycad Toxins: Are microRNAs Common Mediators?Deregulated miRNAs in human cervical cancer: functional importance and potential clinical use.A Comprehensive Review of Dysregulated miRNAs Involved in Cervical Cancer.MicroRNA-584 functions as a tumor suppressor and targets PTTG1IP in glioma.Screening for characteristic microRNAs between pre-invasive and invasive stages of cervical cancer.MicroRNA‑205 promotes the tumorigenesis of nasopharyngeal carcinoma through targeting tumor protein p53-inducible nuclear protein 1.Long non-coding RNA HOTAIR inhibits miR-17-5p to regulate osteogenic differentiation and proliferation in non-traumatic osteonecrosis of femoral head.Differential Sensitivity of Target Genes to Translational Repression by miR-17~92.Tumor Protein 53-Induced Nuclear Protein 1 Enhances p53 Function and Represses Tumorigenesis.Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapesMicroRNA-17-5p promotes gastric cancer proliferation, migration and invasion by directly targeting early growth response 2miR-139-5p is a regulator of metastatic pathways in breast cancer.MiR-17-5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21.Association of the miR-17-5p variants with susceptibility to cervical cancer in a Chinese population.Epigenetics and cervical cancer: from pathogenesis to therapy.Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.A systematic study on dysregulated microRNAs in cervical cancer development.MicroRNA-92a promotes cell viability and invasion in cervical cancer via directly targeting Dickkopf-related protein 3.MicroRNA-17-5p inhibits proliferation and triggers apoptosis in non-small cell lung cancer by targeting transforming growth factor β receptor 2.Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer.miR-17 regulates melanoma cell motility by inhibiting the translation of ETV1.MiR-17-5p up-regulates YES1 to modulate the cell cycle progression and apoptosis in ovarian cancer cell lines.A network-biology perspective of microRNA function and dysfunction in cancer.MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance.MicroRNAs in gynecological cancers: Small molecules with big implications.miR-155 is associated with the leukemogenic potential of the class IV granulocyte colony-stimulating factor receptor in CD34⁺ progenitor cells.MiR-345 suppresses proliferation, migration and invasion by targeting Smad1 in human prostate cancer.Prognostic significance of serum miR-17-5p in lung cancer.MicroRNA-17-5p aggravates lipopolysaccharide-induced injury in nasal epithelial cells by targeting Smad7.MiRNA-106a and prostate cancer radioresistance: a novel role for LITAF in ATM regulation.Prognostic value of miR-17-5 p in gastrointestinal cancers: a systematic review and meta-analysis
P2860
Q27001000-3A03AE00-7D0E-40AB-A334-F78B9AF93050Q27011808-8F89CFEB-B25E-42F5-8502-C96D3180A275Q28389159-E3F75E69-A4AD-4F38-B194-548257BFF60CQ30241934-4434347A-333A-4597-914A-5ACAE0ADE1E8Q34049716-C8A4E159-B531-43B0-BF09-67C221D9AC9CQ35038680-B2C0F661-829C-4E76-B869-CB6805A66848Q35628464-ADD60615-F201-49A8-9508-E98ACCAD7715Q36089751-29C3FC12-F8EA-48A8-88AC-D72F9DE91F94Q36282390-AF51B021-A44F-4C68-AE9E-DF19CE13386DQ36291392-57AC9A51-24D4-4D2E-89C9-53FD8715444EQ36839372-537362AF-1074-46F8-A1FD-EE3AF60EBDAFQ36952911-0BDE04D5-307F-4395-BBDE-C0EB06AEC94AQ37298302-AB94114B-9119-4FA3-9386-170DBCDA06A4Q37448717-4CA6A1DE-5334-46F4-8F6E-DE0762DADAA3Q37577935-29FA47D0-271B-4D89-B4C7-34BE31CCCE97Q37718258-EA499D05-2DCF-4C91-B930-221773AA0027Q38189740-9FC66122-2DAE-4B6D-B597-A8F1FDB63BEEQ38258014-AFE782F2-DB83-414D-BC8C-555A03A3BD68Q38511703-F3CB5778-F25F-45D4-8ED2-DD80470F7D68Q38623605-25E3379A-E362-431D-B86A-461C77497C05Q38701038-6C5449B6-9BB7-4CDD-A835-52A3C74A7D47Q38704340-8F0F5405-7378-4902-8730-B30B818889F4Q38855018-8A7DFF21-C96E-4358-9A49-E077B831424AQ38922911-302FA171-21BA-42DA-8C40-8FD7D58F459FQ38994476-9166F258-BC1A-4B3F-B574-0966C77B0C55Q39037653-7871F188-DD52-4BA2-8164-0014C55B36D3Q39333266-7F2916EB-CF9B-4C37-86A7-E5C28051B7B8Q39675707-81749A62-908C-4633-ACAB-4B5628EE56EAQ40677119-C84FB64E-AAA6-4555-857E-519BC8FADC4EQ44140172-09F7AE72-ADCB-4871-9911-03B83AEF20FEQ49280996-80DB60A8-AB30-4865-AB19-51536DC901BEQ54977715-B3123267-9A31-466A-A5E4-CF282159C4C4Q57073422-C6764627-1137-4D81-8A56-472C682F376A
P2860
MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
MiR-17-5p targets TP53INP1 and ...... osis of cervical cancer cells.
@en
MiR-17-5p targets TP53INP1 and ...... osis of cervical cancer cells.
@nl
type
label
MiR-17-5p targets TP53INP1 and ...... osis of cervical cancer cells.
@en
MiR-17-5p targets TP53INP1 and ...... osis of cervical cancer cells.
@nl
prefLabel
MiR-17-5p targets TP53INP1 and ...... osis of cervical cancer cells.
@en
MiR-17-5p targets TP53INP1 and ...... osis of cervical cancer cells.
@nl
P2093
P2860
P356
P1433
P1476
MiR-17-5p targets TP53INP1 and ...... osis of cervical cancer cells.
@en
P2093
P2860
P304
P356
10.1002/IUB.1051
P577
2012-06-22T00:00:00Z